Announce Date | 02/04/2025 |
EPS Normalized Actual | $5.05 (Beat by $1.83) |
EPS GAAP Actual | $5.05 (Beat by $1.83) |
Revenue Actual | $0.574855B |
Revenue Surprise | Beat by $574.855M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $2.9 |
EPS GAAP Estimate | $2.9 |
Revenue Estimate | $1.5858725B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | 14.31 | 5.88 | 11.83 | 16.79 | 2 |
Dec 2025 | 19 | 4.43 | 19 | 19 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2024 (Sep 2024) | 3.22 | 1.67859 | 0.574855B | 0.87% | -564.87M |
FQ2 2024 (Jun 2024) | 1.96 | 1.96 | 0.495416B | -33.42% | 495.42M |
FQ1 2024 (Mar 2024) | 3.39 | 3.39 | 0.565042B | -21.87% | 565.04M |
FQ4 2023 (Dec 2023) | 5.09 | 5.09 | 0.649439B | 6.24% | 649.44M |
FQ3 2023 (Sep 2023) | 3.11 | 3.11 | 0.569864B | 1.44% | 569.86M |
FQ2 2023 (Jun 2023) | 4.94 | 4.94 | 0.660967B | 17.6% | 660.97M |
FQ1 2023 (Mar 2023) | 6.67 | 6.67 | 0.688607B | 100% | 688.61M |
FQ4 2022 (Dec 2022) | 5.54 | 5.54 | 0.608915B | 100% | 608.92M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
2.9
Consensus Revenue Estimates
1.5858725B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 3 | -- | 2.98047 | 3.01953 | 0 |
FQ3 2026 (Jul 2026) | 2.83 | -- | 2.81157 | 2.84843 | 0 |
FQ2 2026 (Jun 2026) | 2.78 | -- | 2.74402 | 2.81598 | 0 |
FQ1 2026 (Mar 2026) | 3.16 | -- | 3.11911 | 3.20089 | 0 |
FQ4 2025 (Oct 2025) | 3.05 | -- | 3.03014 | 3.06986 | 0 |
FQ3 2025 (Jul 2025) | 2.85 | -12.98 | 2.83144 | 2.86856 | 0 |
FQ2 2025 (Jun 2025) | 2.9 | 32.41 | 2.86247 | 2.93753 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 0.93B | -- | 0.93B | 0.94B | 0 |
FQ3 2026 (Jul 2026) | 0.89B | -- | 0.88B | 0.89B | 0 |
FQ2 2026 (Jun 2026) | 2.22B | -- | 2.2B | 2.24B | 0 |
FQ1 2026 (Mar 2026) | 2.06B | -- | 2.04B | 2.08B | 0 |
FQ4 2025 (Oct 2025) | 0.75B | -- | 0.75B | 0.76B | 0 |
FQ3 2025 (Jul 2025) | 0.71B | 19.25 | 0.71B | 0.72B | 0 |
FQ2 2025 (Jun 2025) | 1.59B | 68.76 | 1.57B | 1.6B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2024 (Sep 2024) | 1.54141 | 3.22 | 1.67859 | 52.13% |
FQ2 2024 (Jun 2024) | 1.96 | 1.96 | 100% | |
FQ1 2024 (Mar 2024) | 3.39 | 3.39 | 100% | |
FQ4 2023 (Dec 2023) | 5.09 | 5.09 | 100% | |
FQ3 2023 (Sep 2023) | 3.11 | 3.11 | 100% | |
FQ2 2023 (Jun 2023) | 4.94 | 4.94 | 100% | |
FQ1 2023 (Mar 2023) | 6.67 | 6.67 | 100% | |
FQ4 2022 (Dec 2022) | 5.54 | 5.54 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2024 (Sep 2024) | $1.14B | $0.57B | $-564.87M | -98.26% |
FQ2 2024 (Jun 2024) | $0B | $0.5B | $495.42M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.57B | $565.04M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.65B | $649.44M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.57B | $569.86M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.66B | $660.97M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.69B | $688.61M | 100% |
FQ4 2022 (Dec 2022) | $0B | $0.61B | $608.92M | 100% |